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Abstract
Objective
We aimed to characterize metabolic status by body mass index (BMI) status.
Methods
The CRONICAS longitudinal study was performed in an age-and-sex stratified random
sample of participants aged 35 years or older in four Peruvian settings: Lima (Peru’s capital,
costal urban, highly urbanized), urban and rural Puno (both high-altitude), and Tumbes
(costal semirural). Data from the baseline study, conducted in 2010, was used. Individuals
were classified by BMI as normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2),
and obese (30 kg/m2), and as metabolically healthy (0–1 metabolic abnormality) or meta-
bolically unhealthy (2 abnormalities). Abnormalities included individual components of the
metabolic syndrome, high-sensitivity C-reactive protein, and insulin resistance.
Results
A total of 3088 (age 55.6±12.6 years, 51.3% females) had all measurements. Of these, 890
(28.8%), 1361 (44.1%) and 837 (27.1%) were normal weight, overweight and obese, respec-
tively. Overall, 19.0% of normal weight in contrast to 54.9% of overweight and 77.7% of
obese individuals had3 risk factors (p<0.001). Among normal weight individuals, 43.1%
were metabolically unhealthy, and age65 years, female, and highest socioeconomic
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groups were more likely to have this pattern. In contrast, only 16.4% of overweight and 3.9%
of obese individuals were metabolically healthy and, compared to Lima, the rural and urban
sites in Puno were more likely to have a metabolically healthier profile.
Conclusions
Most Peruvians with overweight and obesity have additional risk factors for cardiovascular
disease, as well as a majority of those with a healthy weight. Prevention programs aimed at
individuals with a normal BMI, and those who are overweight and obese, are urgently
needed, such as screening for elevated fasting cholesterol and glucose.
Introduction
Obesity, commonly measured using body mass index (BMI), has been associated with a num-
ber of metabolic and cardiovascular disease (CVD) risk factors including an excess mortality
risk [1]. Levels of overweight and obesity in Latin America have increased over time [2] and
have approached levels found in higher-income countries, with a disproportionate increase in
waist circumference compared to BMI over the past 20 years [3, 4]. Overweight and obesity
and are projected to continue rising [5].
The World Health Organization (WHO) recommended cut-off points for overweight and
obesity, at BMI values of 25 kg/m2 and 30 kg/m2, respectively, are based on a large number of
studies in predominantly Caucasian populations. Prior studies in high-income settings have
noted a high prevalence of individuals who are overweight and obese but display normal meta-
bolic features despite their increased adiposity [6–12]. This metabolically healthy obese profile
is controversial: whilst some evidence suggests these individuals are still at increased risk of
developing diabetes [13, 14], CVD [15, 16] and have increased mortality [8], other studies have
found an “obesity paradox” whereby there seems to be a protective effect of obesity from mor-
tality and other chronic conditions [17]. Fasting insulin levels in obese individuals can help fur-
ther differentiate healthy versus unhealthy as increased levels are associated with development
of risk factors for CVD and increased mortality [11, 18, 19]. Conversely, there are also individ-
uals who are normal weight but display metabolically unhealthy features with increased risk of
diabetes and CVD [11, 20, 21]. No prior studies have estimated the prevalence of overweight
and obese individuals and their metabolic risk factors and if these individuals are different with
regards to socio-demographic and behavioral factors in a Latin American population.
As a rapid nutritional transition occurs in Peru [22] and the prevalence of obesity continues
to increase, it is unknown to what extent these profiles exist in this population and whom to
target with public health interventions at the community health worker level. Peru also has
geographical diversity; a pattern shared with other Latin American countries, and differences
in these locations is unknown. Based on BMI, prior studies in Peru have reported a prevalence
of 40% and 15–23% for overweight and obesity, respectively [23, 24], with increased odds of
obesity among those who are older and female [24, 25]. The prevalence of metabolic syndrome
is between 17–25%, depending on which definition is used (American Heart Association or
International Diabetes Federation) [26, 27]. However, none have evaluated the prevalence of
metabolically healthy obese or metabolically unhealthy normal weight individuals in different
settings in Peru. Therefore, we hypothesized that the metabolically healthy obese group com-
pared to the healthy normal weight group was different with regards to socio-demographic and
behavioral factors in a Latin American population. In addition, we hypothesized that the
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metabolically unhealthy normal weight group compared to the metabolically unhealthy over-
weight and obese group had different socio-demographic and behavior factors. Given our
hypotheses, we aimed to use an established definition of metabolic status and to do the follow-
ing: 1) estimate the prevalence of each of the BMI categories (normal weight with and without
metabolic abnormalities, and overweight and obese with and without metabolic abnormalities);
2) determine the prevalence of metabolically healthy obese according to socio-demographic
and behavioral factors; and 3) determine the prevalence of unhealthy metabolic status if nor-
mal weight according to socio-demographic and behavioral factors.
Methods
Study Design, Setting and Participants
The objectives and design of the CRONICAS cohort study have been reported elsewhere [28].
Briefly, a longitudinal study was performed in an age-and-sex stratified random sample of par-
ticipants aged 35 years or older in four Peruvian settings: Lima (Peru’s capital, costal urban,
highly urbanized), urban and rural Puno (both high-altitude), and Tumbes (costal semirural).
Data from the baseline study, conducted in 2010, was used for this study and analysis was com-
pleted in 2014.
Data Collection
A team of community health workers was trained to enroll participants and to conduct the
questionnaires assessing socio-demographic and behavioral variables (Table 1). Variables
included sex, age, study site, education, and socioeconomic status, the latter constructed from
the aggregation of assets and household facilities into a wealth index split in tertiles [29].
Behavioral risk factors included were: current daily smoking, hazardous alcohol drinking [30],
and leisure time and transport-related physical activity (Table 1).
Participants were invited to a clinic visit where height, weight, waist circumference, and sys-
tolic (SBP) and diastolic (DBP) blood pressure, as well as fasting blood samples were obtained
using standardized methods and calibrated tools [28]. Total cholesterol, triglycerides, high-
density lipoprotein cholesterol (HDL-c), insulin, and high-sensitivity C-reactive protein (hs-
CRP) were measured in serum, whereas fasting glucose was assessed in plasma.
Body Size Definitions
Subjects were classified based on BMI as normal weight (18.5–24.9 kg/m2), overweight (25.0–
29.9 kg/m2), and obese (30 kg/m2).
Metabolic Status Definition
Metabolic syndrome and its components were defined according to International Diabetes
Federation criteria [32] (Table 1): waist circumference cutoffs (90 cm in men or80 cm
in women) for South Asian individuals was used as recommended; fasting triglyceride
level150 mg/dL; HDL-c level<40 mg/dL in men<50 mg/dL in women; systolic blood pres-
sure130mmHg, diastolic blood pressure85mmHg, antihypertensive medication, or history
of hypertension [33]; fasting glucose level100 mg/dL or glucose-lowering medication. Ele-
vated hs-CRP (>7.11mg/dL,>90th percentile) and homeostasis model assessment of insulin
resistance value (HOMA-IR) (>5.00,>90th percentile) were used using cut-offs proposed pre-
viously by Wildman et al. [7]. We classified individuals into three risk groups: 0 or 1 abnormal
risk factor, 2 abnormal risk factors, and3 abnormal risk factors by BMI. For the regression
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analysis, individuals were classified as metabolically healthy (0 or 1 abnormal risk factor) or
unhealthy (2 abnormal risk factors), as previously defined [7, 8].
Statistical Analysis
Initially, a description of the socio-demographic, behavioral and clinical variables overall and
according to BMI and metabolic status was performed. Participants that did not have all of the
metabolic factors measured were excluded from the analysis. Geometric means were calculated
for non-normally distributed continuous variables. Differences in these variables among the
three categories (normal weight, overweight, and obese) were analyzed within each metabolic
subgroup using Chi-squared test and one-way analysis of variance.
Table 1. Definition of sociodemographic, behavioral andmetabolic variables.
A. Sociodemographic and behavioral factors considered:
Age groups: 35–44, 45–54, 55–64, 65 years
Education: none or primary (<6 years), secondary (7–11 years) and superior (12 or more years)
Wealth Index: based on assets and household facilities divided into tertiles.
Site: Lima (costal urban), Puno urban (high-altitude urban), Puno rural (high-altitude rural), and Tumbes
(costal rural)
Daily smoking: 1 cigarette/day, self-report.
Alcohol drinking: The Alcohol Use Disorders Identiﬁcation Test [AUDIT] score 8 points for hazardous
drinking [30].
Leisure-time physical activity: Based on leisure time domain of IPAQ as recommended for Latin
American populations [31]. Categories of levels of physical activity were coded based on both total days
of physical activity.
Transport-related physical activity: Based on transport time domain of IPAQ as recommended for Latin
American populations [31]. Categories of levels of physical activity were coded based on both total days
of physical activity.
B. Metabolic abnormalities considered*:
Elevated blood pressure: systolic blood pressure 130mmHg, diastolic blood pressure 85mmHg,
antihypertensive medication, or history of hypertension
Elevated triglyceride level: fasting triglyceride level 150 mg/dL
Decreased HDL-C level: HDL-C level <40 mg/dL in men <50 mg/dL in women
Elevated glucose level: fasting glucose level 100 mg/dL or glucose-lowering medication
Waist circumference: 90 cm in men or 80 cm in women
Insulin resistance: HOMA-IR >5.00 (i.e. >90th percentile)
Systemic inﬂammation: hs-CRP level > 7.11mg/L (i.e. >90th percentile)
C. Criteria for body size and metabolic proﬁles:
Normal weight, metabolically healthy: BMI 18.5–24.9 and <2 risk factors
Normal weight, metabolically unhealthy: BMI 18.5–24.9 and 2 risk factors
Overweight, metabolically healthy: BMI 25.0–29.9 and <2 risk factors
Overweight, metabolically unhealthy: BMI 25.0–29.9 and 2 risk factors
Obese, metabolically healthy: BMI 30.0 and <2 risk factors
Obese, metabolically unhealthy: BMI 30.0 and 2 risk factors
* Based on the International Diabetes Federation’s deﬁnition of metabolic syndrome [32] and Wildman
et al [7].
Abbreviations: METs, metabolic equivalent tasks; HDL-C, high-density lipoprotein cholesterol; HOMA-IR,
homeostasis model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; BMI,
body mass index (calculated as weight in kilograms divided by height in meters squared).
doi:10.1371/journal.pone.0138968.t001
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Among normal weight individuals, prevalence ratios of being metabolically unhealthy were
calculated using socio-demographic and behavioral variables in unadjusted models. Subse-
quently, we used multivariable generalized linear models assuming Poisson distribution of the
outcome and robust standard errors to obtain prevalence ratios (PR) and 95% confidence inter-
vals (95%CI), adjusting for all the variables simultaneously, without and with waist circumfer-
ence into the model. Among overweight and obese individuals, prevalence ratios of being
metabolically healthy were calculated using socio-demographic and behavioral variables in
unadjusted models and subsequently in multivariable generalized linear models as stated previ-
ously. STATA 10 (STATA CORP, College Station, Texas, USA) was used for all analyses.
Ethics
The study was approved by the Institutional Review Boards at Universidad Peruana Cayetano
Heredia and A.B. PRISMA, in Lima, Peru, and at the Bloomberg School of Public Health,
Johns Hopkins University, in Baltimore, USA. All participants provided verbal informed con-
sent after our research team read the entire informed consent document to them and any ques-
tions were answered. Informed consents were verbal because of high illiteracy rates. Both
ethics committees approved the verbal consent procedure.
Results
A total of 3088 (85.4%) of 3618 subjects had all the factors measured. The sample had 51.3%
females and on average the sample age was 55.6 years (SD ±12.6 years). Based on BMI, 890
subjects (28.8%) were normal weight, 1361 (44.1%) were overweight, and 837 (27.1%) were
obese.
Metabolic Risk Profiles
Baseline socio-demographic, behavioral, and clinical variables overall and by BMI categories
and metabolic status are shown in Table 2. Each of the five components of metabolic syndrome
was prevalent in at least 25% of the population. A total of 2263 (73.3%) had elevated waist cir-
cumference, 2048 (66.4%) had low HDL-c, 1329 (43.1%) had elevated triglycerides, 893
(28.9%) had elevated blood pressure, and 798 (25.9%) had impaired fasting glucose.
Fig 1 shows the distribution of number of risk factors by normal weight, overweight and
obese separated by site. As BMI increased, the number of risk factors increased. Overall, 19.0%
of the normal weight group compared to 54.9% of the overweight and 77.7% of the obese
group had3 risk factors (p<0.001), and was consistent at each site.
We next determined if there was a subset of the normal weight group who had multiple
metabolic risk factors despite their normal BMI. Overall, there were a total of 2324 (75.3%) par-
ticipants who were metabolically unhealthy and 16.5% were of normal weight. Within the
unhealthy group, compared to the overweight and obese individuals, those who were normal
weight were more likely to be older, male, live in rural Puno, have less education level, lower
wealth index, and lower physical activity (Table 2). Clinically, they also had lower waist cir-
cumference, higher blood pressure, higher HDL-c, lower hypertriglyceridemia, lower impaired
fasting glucose, and lower HOMA-IR and hs-CRP levels (Table 2).
Alternatively, we determined if there was a subset of the overweight and obese group who
were relatively healthy with either none or 1 metabolic risk factor. Overall, there were 762
(24.7%) participants who were metabolically healthy, and of those, 29.3% were overweight and
4.3% were obese (Fig 1). Within the healthy group with none to 1 metabolic risk factor, com-
pared to the normal weight individuals, those who were overweight and obese were more likely
to be younger, female, live in Tumbes, have higher education level, and higher wealth index.
Metabolic Abnormalities by BodyWeight in South America
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Table 2. Baseline demographic andmetabolic characteristics of the study population by body size.
Metabolically healthy (N = 763) Metabolically unhealthy (N = 2324)
Normal
weight
Overweight Obese p-
value
Normal
weight
Overweight Obese p-
value
N (%) N (%) N (%) N (%) N (%) N (%)
Prevalence 507 (66.5) 223 (29.2) 33 (4.3) 383 (16.5) 1138 (48.9) 804 (34.6)
Sociodemographic
characteristics
Age groups 0.002 <0.001
35–44 years 122 (24.1) 75 (33.6) 9 (27.3) 60 (15.7) 306 (26.9) 185 (23.0)
45–54 years 125 (24.7) 64 (28.7) 9 (27.3) 74 (19.3) 290 (25.5) 228 (28.4)
55–64 years 109 (21.5) 52 (23.3) 8 (24.2) 88 (23.0) 291 (25.6) 235 (29.2)
65 years 150 (29.6) 32 (14.4) 7 (21.2) 161 (42.0) 250 (22.0) 156 (19.4)
Female sex 193 (38.1) 76 (34.1) 22 (66.7) 0.002 199 (52.0) 563 (49.5) 530 (65.9) <0.001
Study site <0.001 <0.001
Lima 131 (25.8) 81 (36.3) 10 (30.3) 103 (26.9) 383 (33.7) 317 (39.5)
Urban Puno 70 (13.8) 54 (24.2) 8 (24.2) 51 (13.3) 204 (17.9) 124 (15.4)
Rural Puno 194 (38.3) 38 (17.1) 3 (9.1) 92 (24.0) 153 (13.4) 50 (6.2)
Tumbes 112 (22.1) 50 (22.4) 12 (36.4) 137 (35.8) 398 (35.0) 313 (38.9)
Education level <0.001 <0.001
None or primary 255 (50.3) 74 (33.3) 14 (42.4) 220 (57.4) 465 (40.9) 384 (47.8)
Secondary 180 (35.5) 88 (39.6) 9 (27.3) 95 (24.8) 378 (33.3) 267 (33.2)
Superior 72 (14.2) 60 (27.1) 10 (30.3) 68 (17.8) 294 (25.9) 153 (19.0)
Socioeconomic status <0.001 <0.001
Lowest (poorest) 243 (47.9) 45 (20.2) 8 (24.2) 156 (40.7) 313 (27.5) 189 (23.5)
Middle 165 (32.5) 85 (38.1) 13 (39.4) 119 (31.1) 382 (33.6) 304 (37.8)
Highest (richest) 99 (19.5) 93 (41.7) 12 (36.4) 108 (28.2) 443 (38.9) 311 (38.7)
Behavioral factors
Smoking 0.38 0.20
Current daily smoking 20 (3.9) 6 (2.7) 0 (0.0) 17 (4.4) 38 (3.3) 20 (2.5)
Alcohol drinking (AUDIT) 0.07 0.14
Hazardous drinking 85 (16.8) 50 (22.4) 3 (9.1) 50 (13.1) 150 (13.2) 83 (10.3)
Physical activity (PA)
Low leisure-time PA 479 (94.5) 208 (93.3) 32 (97.0) 0.64 367 (95.8) 1069 (93.9) 771 (95.9) 0.10
Low transport-related PA 154 (30.4) 64 (28.7) 11 (33.3) 0.82 168 (44.0) 392 (34.5) 309 (38.4) 0.003
Metabolic factors
BMI (kg/m2) 22.5 (1.6) 26.8 (1.3) 32.6 (2.4) <0.001 23.2 (1.5) 27.6 (1.4) 33.5 (3.3) <0.001
Abdominal obesity,% 42 (8.3) 124 (55.6) 33 (100.0) <0.001 198 (51.7) 1063 (93.4) 804 (100.0) <0.001
SBP (mmHg) 111.5 (16.4) 110.9 (11.2) 111.9
(11.4)
0.87 122.0 (21.5) 118.5 (18.9) 120.5 (19.9) 0.004
DBP (mmHg) 69.3 (9.4) 70.0 (7.6) 71.3 (6.4) 0.30 74.0 (12.4) 73.8 (10.6) 76.4 (12.0) <0.001
Elevated blood pressure,% 58 (11.4) 11 (4.9) 0 (0.0) 0.003 168 (43.9) 353 (31.0) 303 (37.7) <0.001
HDL-cholesterol (mg/dL) 50.2 (11.7) 49.9 (10.5) 54.9 (9.8) 0.05 41.4 (10.5) 38.2 (9.6) 37.8 (9.6) <0.001
Low HDL-cholesterol,% 126 (24.9) 30 (13.5) 0 (0.0) <0.001 284 (74.2) 924 (81.2) 685 (85.2) <0.001
Triglycerides (mg/dL) 96.9 (34.6) 102.5 (34.0) 105.9
(25.4)
0.06 158.6 (92.0) 182.9
(112.0)
188.6
(108.6)
<0.001
High triglycerides,% 24 (4.7) 9 (4.0) 0 (0.0) 0.42 172 (44.9) 644 (56.6) 481 (59.8) <0.001
Fasting glucose (mg/dL) 86.6 (12.7) 88.7 (6.9) 87.6 (6.8) 0.07 99.6 (37.6) 99.8 (36.9) 105.7 (39.0) 0.001
Impaired fasting glucose,% 21 (4.1) 5 (2.2) 0 (0.0) 0.23 106 (27.7) 336 (29.5) 330 (41.0) <0.001
Insulin (µU/ml) 4.2 (2.5) 6.3 (3.5) 9.6 (4.3) <0.001 6.5 (4.7) 9.9 (6.8) 15.9 (12.6) <0.001
(Continued)
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Table 2. (Continued)
Metabolically healthy (N = 763) Metabolically unhealthy (N = 2324)
Normal
weight
Overweight Obese p-
value
Normal
weight
Overweight Obese p-
value
N (%) N (%) N (%) N (%) N (%) N (%)
HOMA-IR 0.9 (0.6) 1.4 (0.8) 2.1 (0.9) <0.001 1.6 (1.6) 2.5 (2.3) 4.3 (4.1) <0.001
HOMA-IR > 90th percentile,% 0 (0.0) 0 (0.0) 0 (0.0) — 13 (3.4) 84 (7.4) 212 (26.4) <0.001
High sensitive-CRP (mg/L) 1.9 (5.5) 1.6 (1.5) 2.5 (1.9) 0.46 4.8 (9.9) 3.6 (8.1) 4.4 (5.2) 0.005
hs-CRP > 90th percentile,% 14 (2.8) 1 (0.5) 0 (0.0) 0.08 60 (15.7) 109 (9.6) 125 (15.6) <0.001
Abbreviations: AUDIT, Alcohol Use Disorders Identiﬁcation Test; METs, metabolic equivalent tasks; BMI, body mass index (calculated as weight in
kilograms divided by height in meters); SBP, systolic blood pressure; DBP, diastolic blood pressure; PA, physical activity; HDL-C, high-density lipoprotein
cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein.
SI conversion factors: To convert to milimoles per liter, multiply by 0.0259 for HDL-C, by 0.0113 for triglycerides, and by 0.0555 for glucose; to convert
insulin to picomoles per liter, multiply by 6.945; and hs-CRP to nanomoles per liter, multiply by 9.524.
doi:10.1371/journal.pone.0138968.t002
Fig 1. Prevalence of metabolic status by bodymass index (normal weight, overweight and obese) by site. Abbreviations: BMI, body mass index
(calculated as weight in kilograms divided by height in meters squared).
doi:10.1371/journal.pone.0138968.g001
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Clinically, they also had higher waist circumference, lower blood pressure, and higher HDL-c
(Table 2).
Prevalence of normal weight and metabolic status
The multivariate model using data from normal weight individuals, the metabolic unhealthy
profile was more prevalent in those with older age groups (55–64 years and65 years),
females, those living in Tumbes, higher education level, and highest tertile of wealth index
(Table 3). After adjusting for waist circumference, the oldest age group, female sex, and the
highest tertile of wealth index had a higher prevalence of the unhealthy profiles (Table 3).
Table 3. Unadjusted andmultivariable-adjusted prevalence ratios of the metabolic unhealthy profile associated with socio-demographic and
behaviors variables among normal weight individuals (N = 889).
Unadjusted Multivariable- adjusteda Multivariable-adjusteda
with waist circumference
Prevalence ratios (95% CI)
Age groups
35–44 years 1 Reference 1 Reference 1 Reference
45–54 years 1.13 (0.86–1.48) 1.15 (0.88–1.50) 1.05 (0.81–1.35)
55–64 years 1.35 (1.05–1.76) 1.42 (1.10–1.85) 1.26 (0.98–1.62)
65 years 1.57 (1.24–1.98) 1.68 (1.29–2.18) 1.43 (1.11–1.85)
Sex
Female (vs. male) 1.37 (1.18–1.60) 1.39 (1.19–1.63) 1.69 (1.45–1.97)
Site
Lima 1 Reference 1 Reference 1 Reference
Urban Puno 0.96 (0.74–1.23) 0.86 (0.66–1.13) 0.90 (0.70–1.16)
Rural Puno 0.73 (0.59–0.91) 0.87 (0.67–1.11) 0.98 (0.78–1.24)
Tumbes 1.25 (1.04–1.50) 1.33 (1.09–1.62) 1.11 (0.93–1.34)
Education
None or primary 1 Reference 1 Reference 1 Reference
Secondary 0.75 (0.62–0.90) 0.94 (0.76–1.16) 0.92 (0.75–1.13)
Superior 1.05 (0.86–1.28) 1.31 (1.01–1.69) 1.24 (0.97–1.59)
Wealth Index
Lowest 1 Reference 1 Reference 1 Reference
Middle 1.07 (0.89–1.29) 1.12 (0.92–1.35) 1.01 (0.84–1.21)
Highest 1.33 (1.12–1.60) 1.38 (1.11–1.71) 1.24 (1.02–1.51)
Daily smoking
Current daily smoking (vs. no) 1.07 (0.75–1.53) 0.97 (0.68–1.38) 1.07 (0.77–1.49)
Alcohol drinking
Hazardous drinking (vs. no) 0.84 (0.66–1.06) 1.14 (0.89–1.48) 1.04 (0.81–1.32)
Leisure time physical activity
Moderate/highly active (vs. low) 0.84 (0.56–1.25) 0.81 (0.55–1.18) 0.82 (0.57–1.18)
Transport-related physical activity
Moderate/highly active (vs. low) 0.72 (0.62–0.84) 0.86 (0.73–1.02) 0.91 (0.78–1.06)
Waist circumference, per 5cm 1.29 (1.22–1.36) — 1.30 (1.23–1.37)
Bolded when p-value < 0.05
a. Adjusted for all the variables except for waist circumference in column 2 and all of the variables, including waist circumference in column 3.
doi:10.1371/journal.pone.0138968.t003
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Prevalence of overweight/obese and metabolic status
The metabolically healthy obese profile was more prevalent in those individuals living in urban
and rural Puno, those with secondary or superior education, hazardous drinkers, and those
with high levels of physical activity; whereas, older age groups, male sex, living in Tumbes and
waist circumference had a lower prevalence of the metabolically healthy obese profile. In a mul-
tivariate adjustment, living in urban and rural Puno remained significant with a higher preva-
lence of the healthier profile, while older age groups, male sex, living in Tumbes remained
significant with a lower prevalence of the healthier profile. In a multivariate adjustment model
that included adjusting for waist circumference, only male sex was associated with a lower
prevalence of healthy profile; whereas, living in urban and rural Puno had a higher prevalence
of the healthier profile (Table 4).
Discussion
Main findings
In this study, we report a high prevalence of metabolic abnormalities in Peruvian population.
Among normal weight Peruvians, over one-third were metabolically unhealthy, as high or
higher than estimates reported in developed countries [7, 34]. There were few overweight and
obese individuals with a healthy metabolic profile. Therefore, obesity is highly associated with
having additional risk factors for CVD in this population.
Metabolic profiles in the literature
A prior study using the NHANES data found that 30.1% of normal weight Americans were
metabolically unhealthy, with a slightly higher percentage (32.8%) in Mexican-Americans [7].
In Canada, one study found that 20% of normal weight people were metabolically abnormal by
percentage body fat [34]. Our findings are higher than either of these populations as one-third
were metabolically unhealthy (2 risk factors) with nearly 20% having3 risk factors. While
this is lower than the 54.9% of the overweight and 77.7% of the obese group who had3 risk
factors, it is still concerning as Peru was generally considered to be lagging behind many high-
income settings in the epidemiological transition from infectious diseases to non-communica-
ble diseases [35]. In addition, there has been a rapid nutritional transition over the past 15
years from undernutrition to over nutrition, which may contribute to the high prevalence of
these risk factors [22]. Prevention programs aimed at individuals with a normal BMI, in addi-
tion to those who are overweight, are urgently needed, such as screening for elevated fasting
cholesterol and glucose.
Prior studies in Peru have noted an increased risk of obesity in females [24, 25], but this is
the first study to find that females who are normal weight also have increased risk of being
unhealthy in this population. Prior studies in the United States found that older age, males,
and those with moderate physical activity were correlated with being normal weight and meta-
bolically unhealthy [7]. Our study also found these factors, as well as living in a high-altitude
setting, Puno, had a higher prevalence of the healthier profile. Prior studies have also noted the
benefits of high altitude leading to lower weight and CVD rates [36].
The present analysis expands on previous observations in Caucasian populations that those
with overweight and obesity are a heterogeneous group with regards to their metabolic risk fac-
tors and not all overweight individuals have increased CVD outcomes and mortality. However,
our findings are interesting in that less than 5% of those with obesity have metabolic healthy
profiles. Most studies in Caucasian populations have found much higher prevalence of meta-
bolically healthy obese profile: from 7% (Finland) to 28% (United Kingdom) and 31.7%
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(United States) [7–9, 34]. The reason for this difference is unknown. Correlates of the metabol-
ically healthy obese phenotype in the United States are older age, high physical activity, moder-
ate alcohol use and non-Hispanic black ethnicity [7]. We found a higher prevalence with males
and living in urban and rural Puno in this small metabolically healthy obese group. A recent
meta-analysis suggests that obesity increased all-cause mortality compared to healthy normal
weight individuals and that there is not a protective effect of being obese and healthy [8], argu-
ing against the “obesity paradox” [17]. In addition, elevated waist circumference has been
found to be predictive of mortality at all levels of BMI [37] as well as predict the development
of diabetes [13, 14] and CVD and stroke [16]. The “obesity paradox”, where increased BMI is
protective in some chronic conditions and among older adults [17], is also culturally acceptable
Table 4. Unadjusted andmultivariable-adjusted prevalence ratios of metabolic healthy profile associated with socio-demographic and behaviors
variables among overweight and obese individuals (N = 2198).
Unadjusted Multivariable- adjusteda Multivariable-adjusteda
with waist circumference
Prevalence ratios (95% CI)
Age groups
35–44 years 1 Reference 1 Reference 1 Reference
45–54 years 0.85 (0.62–1.16) 0.85 (0.63–1.15) 0.96 (0.73–1.27)
55–64 years 0.70 (0.50–0.98) 0.72 (0.52–0.99) 0.87 (0.64–1.19)
65 years 0.60 (0.41–0.88) 0.60 (0.40–0.89) 0.82 (0.57–1.18)
Sex
Female (vs. male) 0.52 (0.41–0.67) 0.53 (0.40–0.70) 0.40 (0.31–0.53)
Site
Lima 1 Reference 1 Reference 1 Reference
Urban Puno 1.38 (1.00–1.91) 1.48 (1.06–2.08) 1.63 (1.20–2.23)
Rural Puno 1.46 (1.01–2.11) 1.60 (1.10–2.33) 1.52 (1.04–2.21)
Tumbes 0.70 (0.50–0.96) 0.71 (0.51–0.97) 0.96 (0.70–1.31)
Education
None or primary 1 Reference 1 Reference 1 Reference
Secondary 1.39 (1.04–1.86) 1.01 (0.74–1.37) 1.08 (0.80–1.44)
Superior 1.44 (1.05–1.97) 0.84 (0.56–1.25) 0.88 (0.61–1.27)
Wealth Index
Lowest 1 Reference 1 Reference 1 Reference
Middle 1.31 (0.94–1.83) 1.32 (0.95–1.84) 1.50 (1.07–2.11)
Highest 1.28 (0.92–1.78) 1.22 (0.83–1.78) 1.43 (0.98–2.10)
Daily smoking
Current daily smoking (vs. no) 0.80 (0.36–1.80) 0.78 (0.36–1.68) 0.85 (0.41–1.76)
Alcohol drinking
Hazardous drinking (vs. no) 1.75 (1.29–2.36) 1.11 (0.82–1.50) 1.25 (0.95–1.66)
Leisure time physical activity
Moderate/highly active (vs. low) 1.18 (0.71–1.95) 1.03 (0.64–1.66) 0.87 (0.57–1.33)
Transport-related physical activity
Moderate/highly active (vs. low) 1.31 (1.01–1.73) 0.93 (0.71–1.23) 0.96 (0.74–1.24)
Waist circumference, per 5cm 0.64 (0.58–0.68) — 0.58 (0.53–0.64)
Bolded when p-value < 0.05
a Adjusted for all the variables except for waist circumference in column 2 and all of the variables, including waist circumference in column 3.
doi:10.1371/journal.pone.0138968.t004
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and a social norm in Peru, especially among women. Our findings are very important, as better
public health messaging is needed to counter this belief. The low prevalence of metabolically
healthy overweight and obese individuals is important for both health care providers and pol-
icy makers to understand that obesity is not a protective trait and in fact obesity is associated
with additional risk factors for CVD.
Associated factors
Regarding the individual components of the metabolic syndrome, all five components had a
disturbingly high prevalence—over one-quarter of the population—higher than reported in
prior studies in this region [3, 26, 38–40], with the highest prevalence in abdominal obesity
(73%) and low HDL-c (66.4%). One study found that exercise programs helped individuals
who were metabolically unhealthy and obese become metabolically healthy, yet still obese [41].
Prior studies found the prevalence of overweight and obesity and metabolic syndrome in South
America to vary (overweight prevalence 40–69% and obesity prevalence 11–31%) with Brazil
being the thinnest and Paraguay having the most obese populations [40]. In that study, the
prevalence of obesity in Peru was 16.3%, which is lower than our study where 27.1% are obese.
The prevalence of metabolic syndrome in the CARMELA study was between 14–26%, with
18% in Lima [27]. The PREVENCION study in Peru found the prevalence of metabolic syn-
drome between 17.3%-21.7% in men and 24.0%-25.3% in women depending on which defini-
tion was used (American Heart Association or International Diabetes Federation) [26]. Our
study, which included HOMA-IR and hs-CRP, found a significantly higher prevalence of meta-
bolic abnormalities with 75.1% having2 abnormal risk factors. When we analyzed the num-
ber of metabolic risk factors separately, we found a dose-related response that was consistent
across sites and continued when we looked at 4 or more metabolic risk factors (5.5% of normal
weight, 25.0% of overweight, and 46.7% of obese individuals had 4 or more metabolic risk fac-
tors; p<0.001). One explanation is that there is a strong correlation between BMI and waist cir-
cumference in this population and therefore more overweight and obese individuals were likely
to have at least one metabolic risk factor: increased waist circumference. However, we found
that as BMI increases, the number of additional metabolic risk factors also increases. Elevated
HOMA-IR was present predominantly in those who were overweight and obese, consistent
with prior studies [6, 18].
Prior studies found more individuals who fell into the metabolically healthy obese category
(between 9% to 41%) and found increased mortality in this group, despite varied definitions of
metabolic healthy and unhealthy [12]. In our study, the metabolic healthy profile in obese indi-
viduals is almost non-existent (less than 5%). Overall, this reflects the epidemiologic transition
that is occurring in Peru where non-communicable diseases are becoming more prevalent and
the risk factor profile is similar to many developed countries.
Limitations
This study has some limitations. The definition of metabolic status used in our study was main-
tained similar to other published studied [8, 10, 11, 21, 32, 42] to facilitate meaningful compari-
sons. Therefore, our aim was not to assess individual clinical outcomes by BMI status, but the
seven risk factors as a group. Therefore, as prior studies have done, we excluded those who
were underweight (n = 19), as meaningful comparisons with the other groups, especially with
the large number of individuals in the overweight and obese groups, would have been limited
by power issues. In addition, waist circumference was one of the metabolic risk factors used
previously [8] as abdominal obesity is an important component of the metabolic syndrome
[32] but is closely related to BMI in this population. Lastly, there are no well-established
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definitions of adiposity for Latin America. Therefore, we used Caucasian cut-offs for BMI,
which have not been validated in this population to determine which obesity-related cut-offs
are most predictive of CVD-related morbidity and mortality in this population, including per-
centage body fat and waist circumference. BMI cut-offs still allow for internal comparisons as
random error is expected to be equally distributed across groups. Prospective studies are
needed to determine the risk associated with cardiovascular events in each metabolic group in
this population.
Conclusion
Our study found that most Peruvians with overweight and obesity have additional risk factors
for CVD, as well as a majority of those with a healthy weight. This number is only going to con-
tinue to increase unless national prevention programs are put in place to modify the behavioral
and clinical risk factors, such as those proposed by the American Heart Association or simply
exercise alone [39, 41]. Prevention programs aimed at individuals with a normal BMI, in addi-
tion to those who are overweight and obese, are urgently needed, such as screening for elevated
fasting cholesterol and glucose. Understanding the differential metabolic responses to body
size, its long-term consequences on hard outcomes and their potential to improve cardiovascu-
lar disease screening tools remain as areas of major challenges for cardiovascular disease pre-
vention in low- and middle-income country settings.
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